- Report
- July 2024
- 72 Pages
North America
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- July 2024
- 70 Pages
Africa, Middle East
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- July 2024
- 78 Pages
Europe
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- July 2024
- 78 Pages
Asia Pacific
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- March 2024
- 201 Pages
Middle East, Africa
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Clinical Trials
- April 2024
- 65 Pages
Middle East
From €1043EUR$1,050USD£867GBP
€1490EUR$1,500USD£1,239GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3442EUR$3,465USD£2,862GBP
€4918EUR$4,950USD£4,089GBP
- Report
- June 2024
- 140 Pages
Europe
From €3973EUR$3,999USD£3,303GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3973EUR$3,999USD£3,303GBP
- Report
- September 2024
- 304 Pages
United States
From €2582EUR$2,599USD£2,147GBP
- Report
- May 2024
- 100 Pages
Africa
From €1987EUR$2,000USD£1,652GBP
- Report
- May 2024
- 100 Pages
Africa
From €1987EUR$2,000USD£1,652GBP
- Report
- May 2024
- 80 Pages
United States
From €1490EUR$1,500USD£1,239GBP
The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more